Author

Guo-Yun Li

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

IL20RB drives non-small cell lung cancer progression and immune evasion via K267‑dependent activation of JAK2 phosphorylation and STAT3 signaling.

Pharmacologic suppression of IL20RB by APAP presents a novel therapeutic strategy, positioning IL20RB as a promising prognostic biomarker and therapeutic target in NSCLC.

Yang-Hao Wang, Guo-Yun Li, Wei-Zhou Wang et al. · Lung Cancer · 0 citations